logo
Bondi killer's ‘red flags' before attack

Bondi killer's ‘red flags' before attack

Perth Now22-05-2025

Joel Cauchi was exhibiting 'red flags' that he was relapsing months after he was taken off antipsychotic medication five years before he went on a horrific rampage through Westfield Bondi Junction, a psychiatrist has told an inquest.
An inquest is examining the events that led to Cauchi, 40, killing six people in Sydney's eastern suburbs on April 13, 2024.
Dawn Singleton, Yixuan Cheng, Faraz Ahmed Tahir, Ashlee Good, Jade Young and Pikria Darchia died and another 10 were stabbed by Cauchi before he was shot by police.
Cauchi, who grew up in Toowoomba in Queensland, was diagnosed with schizophrenia when he was 17 and was medicated until he stopped taking all psychotropic medication in June 2019.
His mental health and treatment is one of the issues being probed during the five-week inquest.
From 2001 to 2012, he was managed within the public mental health system with psychotropic medication and from 2012 until February 2020 he was treated by a private psychiatrist.
The inquest previously heard that his private psychiatrist, known as Dr A, had not sought a second opinion when she decided in 2018 to take Cauchi off clozapine - despite doing so when she had begun to gradually reduce his dose in 2015 after he complained of oversedation.
He took abilify to treat obsessive compulsive disorder until he was taken off the medication in June 2019. Westfield Bondi Junction killer Joel Cauchi. Supplied. Credit: Supplied
A panel of five psychiatrists - Professor Matthew Large, Professor Anthony Harris, Professor Edward Heffernan, Professor Olav Nielsen and Denmark-based expert Professor Merete Nordentoft - on Thursday gave evidence to the court about Cauchi's care.
The court has heard that in a termination of treatment notice, Dr A described Cauchi as being treated for 'first episode psychosis' and he had no relapse for 'over 16 years'.
However, the panel of psychiatrists agreed that it was wrong to refer to him as suffering from 'first episode psychosis' and rather he had a chronic condition.
When asked by counsel assisting the coroner Peggy Dwyer whether it was a mistake to initially wean Cauchi off antipsychotic medication, Dr Nielssen told the court: 'Yes, in hindsight'.
'It appears to have been made very much with Mr Cauchi's wishes,' Dr Nielssen said.
Dr Large told the court that: 'We are all subject to outcome bias and hindsight bias.' Bondi stabbing victims Jade Young, Ashlee Good, Dawn Singleton, Cheng Yixuan, Faraz Ahmed Tahir and Pikria Darchia. Credit: Supplied
In late 2019, Cauchi's mother contacted his psychiatrist expressing concerns about his behaviour and a possible relapse.
She said: 'I have noticed a gradual decline in his condition' and she had a feeling he was 'hearing voices'.
She later told one of the nurses at the clinic that he had alluded in a note to being 'under Satanic control'.
Cauchi separately emailed the clinic asking to help him arrange a 'porn-free phone'.
He had initially agreed to go back on a low dose of clozapine however he later changed his mind.
His father Andrew, who the court heard had also suffered from mental illness, was adamant that he did not want his son to go on medication.
Professor Nordentoft said there were 'several red flags' which were raised by Cauchi's mother.
'I agree there are several red flags and I think the most important ones are the ones raised by his mother his knows the most about his condition,' Dr Nordentoft said.
Professor Heffernan agreed there were 'red flags' and Dr Nielsen said that Cauchi was clearly relapsing at that point.
The court was told that the risk of relapse for patients who discontinue anti-psychotic medication was 77 per cent at one year and 80 per cent after two years. While those who remained on medication, the risk of relapse was 10 per cent.
The inquest heard details of his teenage years when he developed psychotic symptoms.
In 2001, Cauchi's father had to move churches because Cauchi believed he was a prophet.
The court was told he went from a scholarship student to experiencing symptoms of psychosis in his final year of school.
He was verbally abusive and aggressive and threatened a person that he had a gun in his bag,
He was hospitalised in early 2001 after he was damaging doors at home, exhibited auditory and visual hallucinations, was paranoid and believed he had been possessed by demons.
The inquest continues.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

'I was going downhill fast': breast cancer drug gives new lease on life
'I was going downhill fast': breast cancer drug gives new lease on life

The Advertiser

time2 days ago

  • The Advertiser

'I was going downhill fast': breast cancer drug gives new lease on life

Mayfield's Madelaine Atkins has a new lease on life from a drug trial that aims to treat advanced breast cancer. She's been part of the FINER clinical trial through the Newcastle-based Breast Cancer Trials for three and a half years. It aims to keep metastatic breast cancer under control for longer. "I feel fantastic. It's created a quality life and freedom for me," said Ms Atkins, 67. "Before I went on the drug trial, I was going downhill fast. My weight was dropping and I was feeling sick and weak." The trial enrolled 250 female and male patients with "advanced ER-positive and HER2-negative breast cancer". The results showed that the addition of the drug ipatasertib to standard treatment "controlled the progress of metastatic breast cancer for almost three times as long". "The main objective of this study was to examine whether treatment with ipatasertib plus fulvestrant was better than fulvestrant alone." Associate Professor Andrew Redfern, chair of the FINER trial, said the results were "significant for these patients with advanced disease". "It could potentially help up to 1500 people in Australia every year who are diagnosed with this type of breast cancer," A/Prof Redfern said. "We now need to confirm these results with longer follow-up of the patients on this trial, as well as further research." Ms Atkins was diagnosed at age 50. "I did chemotherapy, radiation and breast removal," she said. "When I was 60, the little devil came back. It was in my shoulder and started to go up my neck." FINER is a "double-blind placebo-controlled randomised trial". "You don't know which one you get [the drug or placebo]. But here I am, touch wood, in fabulous health with no complaints. It has truly been a blessing to me. "I'm a very positive person. My ethos was I'm not finished yet, so let the game begin." As part of the trial, she receives an "injection in my bottom" each month at Lake Macquarie Private. "We're very lucky to have such great nurses and doctors in Newcastle, let alone Australia," she said. "They'll do anything they can to make your journey that little bit better." She said her partner's support and staying social helped her health journey. "I've been fortunate not to need to work, so I've gone into semi-retirement. "We get away every couple of weeks. It adds that life balance. I'm blessed with great family and friends. "I've enjoyed my life. There's nothing I'd want for except a nice life expectancy." She said there was an upside to going through health challenges. "It shatters you to hear those words [a cancer diagnosis], but it's a strange thing how it can be a blessing," she said. "It wasn't like I got hit by the 207 Merewether bus. If you get hit by a bus, you never get to say goodbye." She said early intervention was key. "I rubbed my neck and it felt like a little pimple the size of a pinhead," she said. "Get it while it's timely and we've got a chance. Let it get to the size of a pea and it's a bigger battle. Get to a strawberry and it's a longer journey." Mayfield's Madelaine Atkins has a new lease on life from a drug trial that aims to treat advanced breast cancer. She's been part of the FINER clinical trial through the Newcastle-based Breast Cancer Trials for three and a half years. It aims to keep metastatic breast cancer under control for longer. "I feel fantastic. It's created a quality life and freedom for me," said Ms Atkins, 67. "Before I went on the drug trial, I was going downhill fast. My weight was dropping and I was feeling sick and weak." The trial enrolled 250 female and male patients with "advanced ER-positive and HER2-negative breast cancer". The results showed that the addition of the drug ipatasertib to standard treatment "controlled the progress of metastatic breast cancer for almost three times as long". "The main objective of this study was to examine whether treatment with ipatasertib plus fulvestrant was better than fulvestrant alone." Associate Professor Andrew Redfern, chair of the FINER trial, said the results were "significant for these patients with advanced disease". "It could potentially help up to 1500 people in Australia every year who are diagnosed with this type of breast cancer," A/Prof Redfern said. "We now need to confirm these results with longer follow-up of the patients on this trial, as well as further research." Ms Atkins was diagnosed at age 50. "I did chemotherapy, radiation and breast removal," she said. "When I was 60, the little devil came back. It was in my shoulder and started to go up my neck." FINER is a "double-blind placebo-controlled randomised trial". "You don't know which one you get [the drug or placebo]. But here I am, touch wood, in fabulous health with no complaints. It has truly been a blessing to me. "I'm a very positive person. My ethos was I'm not finished yet, so let the game begin." As part of the trial, she receives an "injection in my bottom" each month at Lake Macquarie Private. "We're very lucky to have such great nurses and doctors in Newcastle, let alone Australia," she said. "They'll do anything they can to make your journey that little bit better." She said her partner's support and staying social helped her health journey. "I've been fortunate not to need to work, so I've gone into semi-retirement. "We get away every couple of weeks. It adds that life balance. I'm blessed with great family and friends. "I've enjoyed my life. There's nothing I'd want for except a nice life expectancy." She said there was an upside to going through health challenges. "It shatters you to hear those words [a cancer diagnosis], but it's a strange thing how it can be a blessing," she said. "It wasn't like I got hit by the 207 Merewether bus. If you get hit by a bus, you never get to say goodbye." She said early intervention was key. "I rubbed my neck and it felt like a little pimple the size of a pinhead," she said. "Get it while it's timely and we've got a chance. Let it get to the size of a pea and it's a bigger battle. Get to a strawberry and it's a longer journey." Mayfield's Madelaine Atkins has a new lease on life from a drug trial that aims to treat advanced breast cancer. She's been part of the FINER clinical trial through the Newcastle-based Breast Cancer Trials for three and a half years. It aims to keep metastatic breast cancer under control for longer. "I feel fantastic. It's created a quality life and freedom for me," said Ms Atkins, 67. "Before I went on the drug trial, I was going downhill fast. My weight was dropping and I was feeling sick and weak." The trial enrolled 250 female and male patients with "advanced ER-positive and HER2-negative breast cancer". The results showed that the addition of the drug ipatasertib to standard treatment "controlled the progress of metastatic breast cancer for almost three times as long". "The main objective of this study was to examine whether treatment with ipatasertib plus fulvestrant was better than fulvestrant alone." Associate Professor Andrew Redfern, chair of the FINER trial, said the results were "significant for these patients with advanced disease". "It could potentially help up to 1500 people in Australia every year who are diagnosed with this type of breast cancer," A/Prof Redfern said. "We now need to confirm these results with longer follow-up of the patients on this trial, as well as further research." Ms Atkins was diagnosed at age 50. "I did chemotherapy, radiation and breast removal," she said. "When I was 60, the little devil came back. It was in my shoulder and started to go up my neck." FINER is a "double-blind placebo-controlled randomised trial". "You don't know which one you get [the drug or placebo]. But here I am, touch wood, in fabulous health with no complaints. It has truly been a blessing to me. "I'm a very positive person. My ethos was I'm not finished yet, so let the game begin." As part of the trial, she receives an "injection in my bottom" each month at Lake Macquarie Private. "We're very lucky to have such great nurses and doctors in Newcastle, let alone Australia," she said. "They'll do anything they can to make your journey that little bit better." She said her partner's support and staying social helped her health journey. "I've been fortunate not to need to work, so I've gone into semi-retirement. "We get away every couple of weeks. It adds that life balance. I'm blessed with great family and friends. "I've enjoyed my life. There's nothing I'd want for except a nice life expectancy." She said there was an upside to going through health challenges. "It shatters you to hear those words [a cancer diagnosis], but it's a strange thing how it can be a blessing," she said. "It wasn't like I got hit by the 207 Merewether bus. If you get hit by a bus, you never get to say goodbye." She said early intervention was key. "I rubbed my neck and it felt like a little pimple the size of a pinhead," she said. "Get it while it's timely and we've got a chance. Let it get to the size of a pea and it's a bigger battle. Get to a strawberry and it's a longer journey." Mayfield's Madelaine Atkins has a new lease on life from a drug trial that aims to treat advanced breast cancer. She's been part of the FINER clinical trial through the Newcastle-based Breast Cancer Trials for three and a half years. It aims to keep metastatic breast cancer under control for longer. "I feel fantastic. It's created a quality life and freedom for me," said Ms Atkins, 67. "Before I went on the drug trial, I was going downhill fast. My weight was dropping and I was feeling sick and weak." The trial enrolled 250 female and male patients with "advanced ER-positive and HER2-negative breast cancer". The results showed that the addition of the drug ipatasertib to standard treatment "controlled the progress of metastatic breast cancer for almost three times as long". "The main objective of this study was to examine whether treatment with ipatasertib plus fulvestrant was better than fulvestrant alone." Associate Professor Andrew Redfern, chair of the FINER trial, said the results were "significant for these patients with advanced disease". "It could potentially help up to 1500 people in Australia every year who are diagnosed with this type of breast cancer," A/Prof Redfern said. "We now need to confirm these results with longer follow-up of the patients on this trial, as well as further research." Ms Atkins was diagnosed at age 50. "I did chemotherapy, radiation and breast removal," she said. "When I was 60, the little devil came back. It was in my shoulder and started to go up my neck." FINER is a "double-blind placebo-controlled randomised trial". "You don't know which one you get [the drug or placebo]. But here I am, touch wood, in fabulous health with no complaints. It has truly been a blessing to me. "I'm a very positive person. My ethos was I'm not finished yet, so let the game begin." As part of the trial, she receives an "injection in my bottom" each month at Lake Macquarie Private. "We're very lucky to have such great nurses and doctors in Newcastle, let alone Australia," she said. "They'll do anything they can to make your journey that little bit better." She said her partner's support and staying social helped her health journey. "I've been fortunate not to need to work, so I've gone into semi-retirement. "We get away every couple of weeks. It adds that life balance. I'm blessed with great family and friends. "I've enjoyed my life. There's nothing I'd want for except a nice life expectancy." She said there was an upside to going through health challenges. "It shatters you to hear those words [a cancer diagnosis], but it's a strange thing how it can be a blessing," she said. "It wasn't like I got hit by the 207 Merewether bus. If you get hit by a bus, you never get to say goodbye." She said early intervention was key. "I rubbed my neck and it felt like a little pimple the size of a pinhead," she said. "Get it while it's timely and we've got a chance. Let it get to the size of a pea and it's a bigger battle. Get to a strawberry and it's a longer journey."

June push-up challenge for headspace Margaret River to spotlight national suicide crisis
June push-up challenge for headspace Margaret River to spotlight national suicide crisis

West Australian

time2 days ago

  • West Australian

June push-up challenge for headspace Margaret River to spotlight national suicide crisis

Community members are being encouraged to get involved in the local headspace's June Push-Up Challenge. Headspace offices across the country are taking up the task to complete 3214 push-ups in 23 days to honour the number of lives lost to suicide in Australia in 2023. Margaret River-based co-ordinator Dorian De Nobrega said there were great reasons to join the Push-Up Challenge. 'When people register for the challenge, they can choose to help raise vital funds for headspace to support our national youth mental health programs, or directly support their local headspace centre in Bunbury, Busselton or Margaret River,' he said. 'By participating and raising funds for headspace, we will be able to pilot new and innovative programs, grow our reach, and improve mental health outcomes of young people living in the region.' The Push-Up Challenge was created to promote awareness and encourage positive mental health, Mr De Nobrega said. The challenge is described as 'a fun and unique way to engage friends, family, colleagues and community in mental health through connection, physical activity and education'. 'Not only is the challenge lots of fun, but the visibility of it also means it generates conversations in our communities,' Mr De Nobrega said. 'These conversations help to reduce the stigma about mental ill health and encourage seeking help so people who are experiencing challenges don't feel so alone.' Mr De Nobrega stressed participants didn't have to be athletes or undertake any gruelling training regimen. They could instead complete half-push-ups, split the load with a friend, or substitute push-ups for less stressful movements like squats or burpees. To register and find out more, visit .

Named and shamed: Swadesh Indian Restaurant in Baldivis hit with $40k fine for filthy kitchen
Named and shamed: Swadesh Indian Restaurant in Baldivis hit with $40k fine for filthy kitchen

7NEWS

time3 days ago

  • 7NEWS

Named and shamed: Swadesh Indian Restaurant in Baldivis hit with $40k fine for filthy kitchen

An Indian restaurant in Baldivis has been slapped with a fine over a filthy kitchen and dodgy hygiene practices. The owners of Swadesh Indian Restaurant, which has four-and-a-half stars on Google, were fined $40,000 and ordered to pay $24,000 in costs after health inspectors found the kitchen was not up to scratch. The restaurant opened in 2018 and attracts a swathe of good reviews from locals who praise the freshness of dishes and delicious flavours. On Facebook, the team promises to provide 'the freshest ingredients, highest possible quality, all beautifully prepared and presented so that a typical dinner becomes a great experience'. But Swadesh's kitchen has not been up to standard since 2022, when City of Rockingham inspectors found food was not stored in a way to prevent contamination, handwashing facilities were not maintained and there was an accumulation of food waste, dirt and grease. When inspectors returned in 2023, they found the kitchen still hadn't been maintained to the expected standard, with handwashing and dirty equipment found to be a problem yet again. The $40,000 fine is the biggest handed down to a food business in 2025. Last year, Lavoro Italiano Restaurant, also in the City of Rockingham, was fined the same amount when inspectors found crawling cockroaches and cigarette butts in the dry storage. Prosecutors described the kitchen as one of the worst they'd seen in WA, saying: 'Cockroaches seen during the day indicates a serious infestation. When they were pointed out, the owner was not surprised'. But a Nandos in Willetton copped the biggest fine of 2024 when it was hit with $160,000 for being filthy, crawling with rats and selling food past its use-by date. This was followed by Belmont-based Aquarium Seafood Chinese Restaurant, which was fined $80,000 for being filthy and riddled with pests.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store